Catalysts for $IGC
651 tracked
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 13, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 13, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Dec 7, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Jun 26, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Jun 22, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 17, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 17, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 13, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Jun 7, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 7, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 5, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 2, 2023
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Jun 2, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
May 25, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Mar 27, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Mar 23, 2023
approval
PROBUPHINE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→